These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 11302800

  • 1. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A.
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A.
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [Abstract] [Full Text] [Related]

  • 3. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
    Gavaldà J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, Crespo E, Pigrau C, Pahissa A.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.
    Gavaldà J, López P, Martín T, Gomis X, Ramírez JL, Azuaje C, Almirante B, Pahissa A.
    Antimicrob Agents Chemother; 2002 Feb; 46(2):378-84. PubMed ID: 11796345
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J, Moreillon P, Giddey M, Entenza JM.
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [Abstract] [Full Text] [Related]

  • 7. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC, Grayson ML, Eliopoulos GM, Bayer AS.
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M, Perichon B, Lefort A, Carbon C, Courvalin P, Fantin B.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476
    [Abstract] [Full Text] [Related]

  • 10. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Eliopoulos GM, Thauvin-Eliopoulos C, Moellering RC.
    Clin Infect Dis; 1992 Jul; 15(1):58-62. PubMed ID: 1319757
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of teicoplanin, administered in two different regimens, in the treatment of experimental endocarditis due to Enterococcus faecalis.
    Pavleas J, Skiada A, Daikos GL, Pefanis A, Giamarellos-Bourboulis E, Kanellakopoulou K, Tsaganos T, Perrea D, Donta I, Karayannakos P, Giamarellou H.
    J Chemother; 2008 Apr; 20(2):208-12. PubMed ID: 18467247
    [Abstract] [Full Text] [Related]

  • 12. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV, Lopez-Cortes LE, Luque-Marquez R, Galvez-Acebal J, de Alarcon-Gonzalez A.
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.
    Sullam PM, Täuber MG, Hackbarth CJ, Sande MA.
    Antimicrob Agents Chemother; 1985 Jan; 27(1):135-6. PubMed ID: 3157344
    [Abstract] [Full Text] [Related]

  • 14. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR, Wong ES, Coudron PE, Williams DS, Markowitz SM.
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [Abstract] [Full Text] [Related]

  • 15. Teicoplanin in the treatment of enterococcal endocarditis: clinical and microbiological study.
    Venditti M, Tarasi A, Capone A, Galié M, Menichetti F, Martino P, Serra P.
    J Antimicrob Chemother; 1997 Sep; 40(3):449-52. PubMed ID: 9338503
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C, Doria R, Leonildi A, Martinelli C, Menichetti F.
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial activity of gentamicin in experimental enterococcal endocarditis.
    Sullam PM, Täuber MG, Hackbarth CJ, Sande MA.
    Antimicrob Agents Chemother; 1985 Feb; 27(2):224-6. PubMed ID: 3920960
    [Abstract] [Full Text] [Related]

  • 18. Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis.
    Marangos MN, Nicolau DP, Quintiliani R, Nightingale CH.
    J Antimicrob Chemother; 1997 Apr; 39(4):519-22. PubMed ID: 9145826
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.